advisorsecurities master

ALLRAllarity Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11586
Ticker
ALLR
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-12-21
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ALLR

Detail

Enriched 2026-08-14 20:47

Market cap
$22,275,013.6
Shares outstanding (class)
15,910,724
Shares outstanding (weighted)
15,910,724
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
8
Location
BOSTON, MA
Description

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data